The Food and Drug Administration says patients on some popular antidepressants should be closely monitored for warning signs of suicide. The agency asked the makers of 10 drugs to add the caution to their product labels. In changing its requirement, the FDA stressed that it is not yet clear that the drugs actually lead to suicide. NPR's Richard Knox reports.
Copyright 2004 NPR
